Unlock instant, AI-driven research and patent intelligence for your innovation.

BLyS antagonistic peptide SS12, fusion protein SS12-Fc containing antagonistic peptide and gene

A fusion protein, SS12 technology, applied in the field of biomedicine, can solve the problems of short half-life, low efficiency, unstable polypeptide and so on

Inactive Publication Date: 2014-12-10
TIANJIN UNIV
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, peptides also have the disadvantages of instability, low efficiency and short half-life

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • BLyS antagonistic peptide SS12, fusion protein SS12-Fc containing antagonistic peptide and gene
  • BLyS antagonistic peptide SS12, fusion protein SS12-Fc containing antagonistic peptide and gene
  • BLyS antagonistic peptide SS12, fusion protein SS12-Fc containing antagonistic peptide and gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] The structural information of the interaction between BLyS and its receptors and the design of new targeted BLyS antagonistic peptides

[0058] Computer-aided molecular docking and dynamics simulation were used to explore the interaction mode of BLyS and its receptor, and the key amino acid residues that BLyS and its receptor recognize each other were analyzed with the aid of computer graphics and distance geometry.

[0059] Through computer-aided molecular design and high-throughput virtual screening technology, a short peptide that can simulate the key amino acid conformation of the receptor is designed from scratch, and then the role of BLyS and antagonistic peptide can be theoretically evaluated with the help of de novo construction, molecular docking, and dynamic simulation; computer graphics To evaluate the potential biological effects of antagonistic peptides by scientific technology, distance geometry and intermolecular hydrogen bonding. After theoretical screening, ...

Embodiment 2

[0061] The plasmids SS12-Fc-pET30a and 3SS12-Fc-pET30a containing SS12-Fc and 3SS12-Fc fusion protein genes were constructed respectively ( figure 1 ).

[0062] 2.1 The gene encoding the BLyS antagonistic peptide SS12 was constructed using the following method: According to the amino acid sequence of the antagonistic peptide SS12, we designed two DNA primers encoding short peptides and ordered them to synthesize them through the company.

[0063] The upstream primer of SS12 is shown in SEQ ID NO.5, and the downstream primer of SS12 is shown in SEQ ID NO.6

[0064] The synthesized DNA primers of SS12 were dissolved by adding 200μl of 10mM Tris-Hcl (pH8.5) (final concentration of 16pmol / μl). Take 20μl of the positive and negative strands of the SS12 gene, mix them in an EP tube, boil in a water bath at 100°C for 3 minutes, and gradually cool to room temperature. Use 2% agarose gel electrophoresis to observe the annealing results. The result of electrophoresis showed that there is a c...

Embodiment 3

[0078] Induction and expression of SS12-Fc and 3SS12-Fc fusion proteins

[0079] The correctly sequenced recombinant plasmids SS12-Fc-pET30a and 3SS12-Fc-pET30a were respectively transformed into the expression host strain E. Coli. BL21 for high expression strain screening, and it was found that the concentration of IPTG was 0.5 mM, and it was shaken slowly at 16°C. Under the conditions of induction, the target protein can be induced. Highly expressing strains were selected for large-scale expression, purified by protein A gel affinity chromatography column, collected the eluate, dialyzed in 1×PBS, and measured with a UV spectrophotometer to calculate the protein concentration of SS12-Fc as 700ng / μl, 3SS12 -Fc protein concentration is 1400ng / μl. After dialysis, the target protein was subjected to SDS-PAGE electrophoresis. It was found that the sizes of SS12-Fc and 3SS12-Fc proteins were 25.4kDa and 28.6kDa, respectively, which were the same size as SS12-Fc and 3SS12-Fc, and had ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses BLyS antagonistic peptide SS12, fusion protein SS12-Fc containing the antagonistic peptide and a gene. Experiments prove that SS12-Fc and 3SS12-Fc fusion protein can be combined with BLyS and interaction between BLyS and BCMA and interaction between BLyS and TACI are inhibited. SS12-Fc and 3SS12-Fc fusion protein guarantee the stability of spatial structures of SS12 and 3SS12 without weakening the activity of peptide, and SS12 and 3SS12 contain Fc tags and can be easily purified and detected, so that SS12-Fc and 3SS12-Fc, which serve as BLyS antagonists, can be applied to potential medicines for treating autoimmunity diseases and lymphoma.

Description

Technical field [0001] The present invention belongs to the field of biomedicine, and particularly relates to BLyS antagonistic peptides, and fusion proteins, genes and plasmids containing BLyS antagonistic peptides. Background technique [0002] B lymphocyte stimulator (BLyS), also known as B cell activating factor (B cell activating factor belonging to the TNF family, BAFF), is a member of the TNF family. It is continuously synthesized and secreted by monocytes and macrophages. BLyS can bind to three receptors on the surface of B cells, B cell mature antigen (BCMA), transmembrane activator and CAML-interactor (TACI) and BLyS receptor 3 (BR3) ). After the receptor binds to BLyS, it couples with TNF receptor associated factor (TRAF) to activate the NF-ΚB pathway. Finally, induce the expression of anti-apoptotic genes: Bcl-2, Bcl-xL, and reduce the apoptosis of mature B cells. If BLyS is knocked out, the mature B cells in the mouse are completely lost. Therefore, BLyS plays a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/08C07K19/00C12N15/62C12N15/70C12N15/66
Inventor 孙剑冯建男臧孟存沈倍奋
Owner TIANJIN UNIV